Our Services
Medical Information
Helpful Resources
Published on: 3/2/2026
Waking up stiff for an hour or more, especially in shoulders and hips after age 50, often points to polymyalgia rheumatica, which is diagnosed by symptom pattern with ESR or CRP and rapid improvement on low dose prednisone; treatment usually means a medically supervised steroid taper over 1 to 2 years plus bone protection and gentle movement.
There are several factors to consider, and urgent care is needed for new headaches, jaw pain, scalp tenderness, or vision changes that suggest giant cell arteritis; see below for complete medically approved next steps, including testing, how to start and taper steroids safely, monitoring for side effects, and lifestyle measures that can change your plan.
If you wake up feeling unusually stiff—especially in your shoulders, neck, or hips—and it takes an hour or more to loosen up, your body may be signaling inflammation. One condition strongly linked to this pattern is polymyalgia rheumatica.
Polymyalgia rheumatica (PMR) is an inflammatory disorder that primarily affects adults over age 50. It can come on quickly, often over days to weeks, and it can significantly affect daily life. The good news: it is treatable, and most people improve dramatically with proper medical care.
Let's walk through what polymyalgia rheumatica is, why it causes stiffness, and what medically approved next steps look like.
Polymyalgia rheumatica is an inflammatory condition that causes muscle pain and stiffness, especially in:
The word breaks down as:
Despite the name, the pain isn't actually from the muscles themselves. The inflammation affects the joints and surrounding tissues, especially bursae (fluid-filled sacs that cushion joints).
Inflammation follows a daily rhythm. In polymyalgia rheumatica, inflammatory chemicals increase overnight. That's why symptoms are usually worst:
Morning stiffness lasting more than 45–60 minutes is a key feature. Some people describe it as:
This stiffness improves as you move—but may return after rest.
Polymyalgia rheumatica almost always affects people:
It is not caused by exercise, injury, or "sleeping wrong." It is an immune-mediated inflammatory condition.
In addition to stiffness and aching, polymyalgia rheumatica may cause:
Some people also develop a related condition called giant cell arteritis (GCA), which is more serious. Symptoms of GCA include:
If you experience these symptoms, seek urgent medical care. Vision complications can become permanent if untreated.
There is no single test for polymyalgia rheumatica. Doctors diagnose it based on:
Doctors often check markers of inflammation:
These are usually elevated in polymyalgia rheumatica, though not always.
One hallmark feature: symptoms improve rapidly—often within 24 to 72 hours—after starting low-dose corticosteroids.
If you're experiencing these symptoms and want to understand whether they could be related to Polymyalgia Rheumatica, a free AI-powered symptom checker can help you assess your risk and prepare informed questions before your medical appointment.
The standard treatment is low-dose corticosteroids, usually prednisone.
Polymyalgia rheumatica is driven by inflammation. Corticosteroids:
Most people feel significantly better within days. That rapid improvement is both therapeutic and diagnostic.
Treatment typically lasts:
The dose is gradually tapered (lowered) over time. Stopping too quickly can cause symptoms to return.
This is not a condition that usually resolves in a few weeks. It requires careful medical supervision.
Steroids are effective—but long-term use carries risks. These may include:
Because of this, doctors usually:
It's important not to stop steroids suddenly without medical guidance.
Medication is central, but supportive steps matter too.
Movement helps reduce stiffness and maintain strength.
Since steroids can weaken bones:
An anti-inflammatory eating pattern may help overall health:
Diet alone will not cure polymyalgia rheumatica, but it supports recovery.
It's helpful to clarify what PMR is often confused with:
If stiffness is severe, persistent, and symmetrical—especially over age 50—it deserves evaluation.
Seek urgent medical care if you have:
These may signal giant cell arteritis, which can threaten vision if untreated.
Even if symptoms feel mild, persistent morning stiffness lasting more than a few weeks should be evaluated. Early treatment prevents unnecessary suffering and complications.
The overall outlook for polymyalgia rheumatica is good with treatment.
Most people:
Relapses can happen, especially during dose reductions, but they are manageable with medical supervision.
Polymyalgia rheumatica is not typically life-threatening on its own—but complications (like giant cell arteritis or long-term steroid side effects) require careful monitoring.
If you are waking up stiff and sore for over an hour each morning—especially if you're over 50—don't ignore it. Persistent inflammation is not just "getting older."
Polymyalgia rheumatica is:
Early evaluation makes a significant difference in comfort and long-term health.
If your symptoms match what you've read, consider completing a free, online symptom check for Polymyalgia Rheumatica and then bring the results to your healthcare provider for discussion.
Most importantly, speak to a doctor about any ongoing stiffness, inflammation, vision changes, or severe symptoms. Only a qualified medical professional can diagnose polymyalgia rheumatica and rule out serious or life-threatening conditions.
You do not have to accept severe morning stiffness as your new normal. With proper medical care, most people feel dramatically better—and regain control of their daily lives.
(References)
* Salvarani C, Dejaco C, Duftner C, Macchioni P, Monti S, Pedrazzi I, Ponte C, Schirmer M, Seifert M, Tanturri L, Tempesta D, Wagner AD, Wipfler-Pfeiffer E, Zink A, Schirmer M. 2023 EULAR recommendations for the management of polymyalgia rheumatica. Ann Rheum Dis. 2023 Nov 2:ard-2023-224699. doi: 10.1136/ard-2023-224699. Epub ahead of print. PMID: 37914488.
* Picco R, Alunno A. Pathophysiology and novel therapeutic targets in polymyalgia rheumatica. Autoimmun Rev. 2023 Feb;22(2):103254. doi: 10.1016/j.autrev.2022.103254. Epub 2022 Dec 17. PMID: 36535560.
* Capra M, Dejaco C. Challenges in Polymyalgia Rheumatica. J Clin Med. 2022 Mar 22;11(6):1709. doi: 10.3390/jcm11061709. PMID: 35330058; PMCID: PMC8956977.
* Dejaco C, Brouwer E, Mason JC, Buttgereit F, Salvarani C, Manger B, Dasgupta B. Giant cell arteritis and polymyalgia rheumatica: current views on pathophysiology, clinical features and treatment. Nat Rev Rheumatol. 2017 Nov;13(11):688-700. doi: 10.1038/nrrheum.2017.151. Epub 2017 Oct 13. PMID: 29026117.
* Dasgupta B, Cimmino MA, Maradit-Kremers R, Schmidt WA, Schirmer M, Salvarani C, Miller A, Bond M, Curiale C, Dejaco C, Dix R, Falcini F, Hauenstein C, Healey S, Knudsen LS, Landman R, Neill L, Nannini C, Piper J, Schmidt J, Slooten E, Tamborrini G, Wagner AD, Whitlock M, Pike M, Younge BR. 2012 Provisional Classification Criteria for Polymyalgia Rheumatica: A Consensus-Based Study from the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Ann Rheum Dis. 2012 Oct;71(10):1777-84. PMID: 22896500.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.